Search research articles
Contact Us
Filters
Showing results (11-20 of 47) with videos related to
Page
of 5
Sort By:
The Journal of Heart Transplantation
|
July 1, 1989
Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation
M P Macris, O H Frazier, D Lammermeier, et al.
The Journal of Heart Transplantation
|
January 1, 1989
Heterotopic heart transplantation: a reliable option for a select group of high-risk patients
T Nakatani, O H Frazier, D E Lammermeier, et al.
The Journal of Heart Transplantation
|
November 1, 1989
Predictors of severe renal dysfunction after heart transplantation and intravenous cyclosporine therapy
M P Macris, E G Ford, C T Van Buren, et al.
Texas Heart Institute Journal
|
January 1, 1988
Cardiac transplantation in a Jehovah's witness
D E Lammermeier, J M Duncan, R C Kuykendall, et al.
ASAIO Transactions
|
July 1, 1988
Simplified method of hemofiltration in ventricular assist device patients
M P Macris, C G Barcenas, S M Parnis, et al.
Transplantation Proceedings
|
June 1, 1988
Analysis of rejection in cyclosporine-treated cardiac allograft recipients
M P Macris, O H Frazier, T Burstein, et al.
The Annals of Thoracic Surgery
|
February 1, 1997
Development of an implantable ventricular assist system
M P Macris, S M Parnis, O H Frazier, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 1, 1995
Hospital charges for conventional therapy versus left ventricular assist system therapy in heart transplant patients
M J Cloy, T J Myers, L A Stutts, et al.
Circulation
|
April 15, 1995
Sixty-eight-year-old woman with intermittent hypoxemia
W E Dear, P Chen, E Barasch, et al.
The Journal of Heart Transplantation
|
July 1, 1989
Selective use of OKT3 in heart transplantation with the use of risk factor analysis
M P Macris, C T Van Buren, M S Sweeney, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 47) with videos related to
Sort By:
Page
of 5
The Journal of Heart Transplantation
|
July 1, 1989
Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation
M P Macris, O H Frazier, D Lammermeier, et al.
The Journal of Heart Transplantation
|
January 1, 1989
Heterotopic heart transplantation: a reliable option for a select group of high-risk patients
T Nakatani, O H Frazier, D E Lammermeier, et al.
The Journal of Heart Transplantation
|
November 1, 1989
Predictors of severe renal dysfunction after heart transplantation and intravenous cyclosporine therapy
M P Macris, E G Ford, C T Van Buren, et al.
Texas Heart Institute Journal
|
January 1, 1988
Cardiac transplantation in a Jehovah's witness
D E Lammermeier, J M Duncan, R C Kuykendall, et al.
ASAIO Transactions
|
July 1, 1988
Simplified method of hemofiltration in ventricular assist device patients
M P Macris, C G Barcenas, S M Parnis, et al.
Transplantation Proceedings
|
June 1, 1988
Analysis of rejection in cyclosporine-treated cardiac allograft recipients
M P Macris, O H Frazier, T Burstein, et al.
The Annals of Thoracic Surgery
|
February 1, 1997
Development of an implantable ventricular assist system
M P Macris, S M Parnis, O H Frazier, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|
July 1, 1995
Hospital charges for conventional therapy versus left ventricular assist system therapy in heart transplant patients
M J Cloy, T J Myers, L A Stutts, et al.
Circulation
|
April 15, 1995
Sixty-eight-year-old woman with intermittent hypoxemia
W E Dear, P Chen, E Barasch, et al.
The Journal of Heart Transplantation
|
July 1, 1989
Selective use of OKT3 in heart transplantation with the use of risk factor analysis
M P Macris, C T Van Buren, M S Sweeney, et al.
Page
of 5